NCT05281692View on ClinicalTrials.gov

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX )

CompletedOBSERVATIONAL
Enrollment

205

Participants

Timeline

Start Date

February 2, 2022

Primary Completion Date

March 21, 2022

Study Completion Date

March 21, 2022

Conditions
SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Enhanced Preservation Media (EPM-IX)

EPM-IX is a clinical specimen collection medium that inactivates pathogens, preserves nucleic acids, and integrates DNA/RNA purification. EPM-IX eliminates the need for additional extraction reagents or kits and purifies DNA/ RNA from the entire sample to enable optimal test performance.

Trial Locations (1)

60657

UroPartners Urology Group, Chicago

Sponsors
All Listed Sponsors
lead

Convergent Genomics, Inc.

NETWORK